Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study (Q27851561)

13 November 2016

title

Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study (English)

1 reference

13 November 2016

0 references

0 references

Frederick R. Appelbaum

21

object named as

F R Appelbaum

0 references

Cheryl L. Willman

18

object named as

C L Willman

0 references

author name string

P A Ho

1

0 references

T A Alonzo

2

0 references

K J Kopecky

3

0 references

K L Miller

4

0 references

J Kuhn

5

0 references

R Zeng

6

0 references

R B Gerbing

7

0 references

S C Raimondi

8

0 references

B A Hirsch

9

0 references

V Oehler

10

0 references

C A Hurwitz

11

0 references

J L Franklin

12

0 references

A S Gamis

13

0 references

S H Petersdorf

14

0 references

J E Anderson

15

0 references

G H Reaman

16

0 references

L H Baker

17

0 references

I D Bernstein

19

0 references

J P Radich

20

0 references

D L Stirewalt

22

0 references

S Meshinchi

Recurring mutations found by sequencing an acute myeloid leukemia genome

23

0 references

publication date

May 2010

0 references

published in

Leukemia

0 references

volume

24

0 references

issue

5

0 references

page(s)

909-13

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945692

Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945692

IDH1 and IDH2 mutations in gliomas

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945692

An integrated genomic analysis of human glioblastoma multiforme

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945692

PI3K/PTEN signaling in angiogenesis and tumorigenesis

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945692

Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945692

Development of HIF-1 inhibitors for cancer therapy

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945692

Hypoxia. Hypoxia, hypoxia inducible factor and myeloid cell function

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945692

IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945692

Analysis of the IDH1 codon 132 mutation in brain tumors

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945692

Size of FLT3 internal tandem duplication has prognostic significance in patients with acute myeloid leukemia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945692

Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945692

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

29 September 2017

1 reference

Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers

21 January 2018

1 reference

FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia.

21 January 2018

1 reference

Frequent IDH1 mutations in supratentorial primitive neuroectodermal tumors (sPNET) of adults but not children.

21 January 2018

1 reference

Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/20376086

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: a Southwest Oncology Group study (SWOG-9500)

1 reference

https://pubmed.ncbi.nlm.nih.gov/20376086

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/LEU.2010.56

0 references

Dimensions Publication ID

0 references

1 reference

13 November 2016

1 reference